Elequin Capital’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $932 | Buy |
+39
| New | +$932 | ﹤0.01% | 288 |
|
|
2025
Q1 | – | Sell |
-4
| Closed | -$75 | – | 527 |
|
|
2024
Q4 | $75 | Sell |
4
-243
| -98% | -$4.56K | ﹤0.01% | 473 |
|
|
2024
Q3 | $3.72K | Buy |
+247
| New | +$3.72K | ﹤0.01% | 299 |
|
|
2024
Q2 | – | Sell |
-7
| Closed | -$205 | – | 307 |
|
|
2024
Q1 | $205 | Buy |
+7
| New | +$205 | ﹤0.01% | 223 |
|
|
2023
Q3 | – | Sell |
-69
| Closed | -$2.77K | – | 557 |
|
|
2023
Q2 | $2.77K | Buy |
+69
| New | +$2.77K | ﹤0.01% | 420 |
|
|
2022
Q3 | – | Sell |
-212
| Closed | -$12K | – | 645 |
|
|
2022
Q2 | $12K | Sell |
212
-23
| -10% | -$1.3K | ﹤0.01% | 223 |
|
|
2022
Q1 | $18K | Buy |
+235
| New | +$18K | ﹤0.01% | 128 |
|